000			01609 a2200493 4500
005			20250517150832.0
264		0	_c20181025
008			201810s 0 0 eng d
022			_a1573-2509
024	7		_a10.1016/j.schres.2017.04.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aMezquida, G
245	0	0	_aInverse association between negative symptoms and body mass index in chronic schizophrenia. _h[electronic resource]
260			_bSchizophrenia research _c02 2018
300			_a69-74 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAntipsychotic Agents _xtherapeutic use
650	0	4	_aBenzodiazepines _xtherapeutic use
650	0	4	_aBody Mass Index
650	0	4	_aChronic Disease
650	0	4	_aClozapine _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aOlanzapine
650	0	4	_aPrincipal Component Analysis
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aRegression Analysis
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aSchizophrenic Psychology
700	1		_aSavulich, G
700	1		_aGarcia-Rizo, C
700	1		_aGarcia-Portilla, M P
700	1		_aToll, A
700	1		_aGarcia-Alvarez, L
700	1		_aBobes, J
700	1		_aMané, A
700	1		_aBernardo, M
700	1		_aFernandez-Egea, E
773	0		_tSchizophrenia research _gvol. 192 _gp. 69-74
856	4	0	_uhttps://doi.org/10.1016/j.schres.2017.04.002 _zAvailable from publisher's website
999			_c27083551 _d27083551